Critical Care

official impact factor 4.60

Download references

This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Highly Access

Pharmacodynamic optimization of β-lactams in the patient care setting

David P Nicolau

Critical Care 2008, 12(Suppl 4):S2 doi:10.1186/cc6818

Include


Format